GM16395
Fibroblast from Skin, Unspecified
Description:
GLUTARICACIDEMIA I
GLUTARYL-COA DEHYDROGENASE; GCDH
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Amino Acid Metabolism |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
GCDH |
Chromosomal Location |
19p13.2 |
Allelic Variant 1 |
R257W; GLUTARICACIDEMIA I |
Identified Mutation |
ARG257TRP |
|
Gene |
GCDH |
Chromosomal Location |
19p13.2 |
Allelic Variant 2 |
R294Q; GLUTARICACIDEMIA I |
Identified Mutation |
ARG294GLN |
Remarks |
Clinically affected; donor subject is a compound heterozygote: one allele carries a C-to-T transition (CGG>TGG) at nucleotide 805 (c.769) in exon 7 of the GCDH gene which results in a substitution of tryptophan for arginine at codon 257 [Arg257Trp (R257W)]; the second allele carries a G>A transition at nucleotide c.881 in exon 8 resulting in a substitution of glutamine for arginine at codon 294 [Arg294Gln (R294Q)] |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|